COST-EFFECTIVENESS ANALYSIS OF UMECLIDINIUM BROMIDE/VILANTEROL 62.5/25 MCG VERSUS TIOTROPIUM/OLODATEROL 5/5 MCG IN SYMPTOMATIC PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN

Driessen, M.Whalen, J.Buguth, Seewoodharry B.Vallejo-Aparicio, L. A.Naya, IAsukai, Y.Alcazar-Navarrete, B.Miravitlles, M.Garcia-Rio, F.Risebrough, N.2025-01-072025-01-072018-05-011098-3015https://hdl.handle.net/10668/24828enCOST-EFFECTIVENESS ANALYSIS OF UMECLIDINIUM BROMIDE/VILANTEROL 62.5/25 MCG VERSUS TIOTROPIUM/OLODATEROL 5/5 MCG IN SYMPTOMATIC PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAINconference outputopen access10.1016/j.jval.2018.04.15831524-4733http://www.valueinhealthjournal.com/article/S1098301518318898/pdf438630000636